THE USE OF PARNATE IN THE TREATMENT OF DEPRESSION
MILTON H. MILLER M.D.1
1 Associate Professor of Psychiatry, University of Wisconsin, Madison, Wis.
Six months of clinical experience with a new antidepressant medication, Parnate (tranylcypromine), indicates that this compound is a very effective monoamine oxydase inhibitor. It appears to act fairly rapidly in a wide variety of depressive states and in this examiner's hands seemed to effect remission in several very refractory depressive illnesses. It would appear to be indicated in the treatment of any form of depression and warrants trial in some long depressive illnesses which had been nonresponsive to other therapies.
